New Covid nasal spray outperforms current antibody treatments in mice
There's a widely available OTC nasal spray that has been used for years against various respiratory viruses, which became engaged in a regulatory debate.<p><a href="https://finance.yahoo.com/news/nathan-jones-ceo-xlear-inc-113000529.html" rel="nofollow">https://finance.yahoo.com/news/nathan-jones-ceo-xlear-inc-11...</a><p><i>> The Government tells people to wash their hands; Yet COVID-19 is an upper respiratory illness. Most COVID-19 infections start in the nose. It makes commonsense to wash your nose. People have been using nasal cleansing to fight respiratory illnesses going back thousands of years.</i><p>March 2021, <a href="https://www.businesswire.com/news/home/20210324005241/en/Xlear-Submits-COVID-19-Pre-Emergency-Use-Authorization-Request-with-FDA-Regarding-Use-of-Xlear-Nasal-Spray-in-Help-in-Combating-SARS-CoV-2" rel="nofollow">https://www.businesswire.com/news/home/20210324005241/en/Xle...</a><p><i>> Xlear previously filed a pre-EUA seeking approval for use of the nasal spray as a medical device in combatting COVID-19. However, because the FDA determined that Xlear “works against the virus,” the FDA told Xlear it would need to be considered as a drug or combination product EUA. Xlear is currently sold in over 50,000 pharmacies, grocery stores, and online as a nasal spray. “Xlear doesn’t require the EUA to be sold and used—we only need an EUA to be able to inform people about the benefits of using Xlear to protect themselves from COVID-19".</i>